全球醫療包裝市場：2024-2031年

醫療保健成本不斷上漲和合規要求日益嚴格，正推動醫療和藥品包裝產業發生變革性成長。

本研究報告對全球醫療包裝市場進行了全面分析，詳細考察了2021年至2031年的區域細分、收入指標和材料趨勢。透過檢驗歷史數據並預測未來趨勢，該報告提供了2025年至2031年的七年預測，其中2024年為基準年。

• 依產品類型：藥品包裝、醫療設備包裝、醫用輸液袋
• 依材質分類：塑膠、玻璃、其他（包括金屬、紙基材料和複合材料）
• 按地區分類：美洲、歐洲、亞太地區、中東、南亞和非洲（MEASA）

以美國為首的美洲地區憑藉其在先進藥品和醫療設備製造領域的領先地位、完善的醫療基礎設施以及對專業包裝創新技術的廣泛應用，構成了醫療保健包裝的重要市場。歐洲擁有成熟的醫療保健包裝市場，這主要得益於其嚴格的法規環境，強調病人安全和永續性。市場動態表明，醫療保健包裝的普及速度正在加快，其中亞太地區是醫療保健包裝成長最強勁的市場，中國、日本和新興國家正在推動生產和消費的顯著成長。

調查方法對每種包裝類別、材料類型和地區的收入進行了深入分析，從而揭示了推動成長的因素和潛在挑戰。預測基於預期的年複合成長率（CAGR），為市場發展趨勢提供了策略視角。

收入和預測

基準年的預計收入為 1,048.7 億美元，預計在 2024-2031 年的研究期間內，年複合成長率將達到 7.0%。

三大策略挑戰對醫療包裝產業的影響

變革性大趨勢

原因

• 加州《無毒醫療設備法案》將於2030年前禁止使用含有鄰苯二甲酸二(2-乙基己基)酯（DEHP）的靜脈輸液用品，該法案針對的材料佔某些醫療設備總量的80%之多。 DEHP是塑化劑，可賦予聚氯乙烯（PVC）柔韌性，並與多種癌症相關，包括乳癌、肝癌、肺癌和睪丸癌。
• 醫療產品中鄰苯二甲酸二(2-乙基己基)酯（DEHP）的含量可能高達40%（以重量計），這會污染患者使用的藥物和輸液。這對癌症患者構成特別嚴重的風險，因為DEHP會促進抗藥性並降低化療的療效。歐盟透過醫療器材法規（MDR）和歐盟環境、法規及相關法規（REACH）制定了類似的法規，要求所有含有DEHP的醫療器材必須在2030年7月前獲得批准或召回。

弗羅斯特的展望

• 未來三到五年內，儘管成本高昂，製造商仍需投資改造非PVC材料的生產線和檢驗流程。領導者正在開發能夠去除鄰苯二甲酸二辛酯（DEHP）、塑化劑和鄰苯二甲酸酯的解決方案。
• 這些新產品透過優先排序和廣泛檢驗展現了行業領先地位。隨著加州禁令於2023年生效，早期市場定位表明，能夠證明其永續性和安全性的合規公司可以避免市場中斷，並透過合規性每年節省500萬美元。

顛覆性技術

原因

• 製藥業正迅速轉向生物製藥，生物製劑由源自活體生物的複雜蛋白質、抗體和活細胞生物來源。與小分子藥物不同，生物製藥對環境因素（例如溫度、光照、濕度和表面相互作用）高度敏感，暴露於不利條件下會加速其分解，例如透過氧化、變性和聚集等機制。
• 傳統包裝材料可能缺乏所需的化合物或足夠的阻隔性能。生技藥品通常需要精確的低溫運輸管理（有時需要在超低溫下進行），避免機械應力，並使用能最大限度減少蛋白質在表面吸附的材料，以確保其在整個保存期限內的治療效果。

弗羅斯特的展望

• 未來三到五年內，藥品包裝製造商需要開發專為生物製藥最佳化的專用材料和輸送系統。這將涉及大規模的研發工作，以充分發揮其固有的阻隔性能，抵禦溫度、濕度和機械應力，同時確保產品完整性。製造商需要專注於開發技術解決方案，以實現更清潔的生產過程。
• 生產靈活性至關重要：無塵室共享將成為新常態，使製造商能夠實現產品組合多元化，以滿足生技藥品和製藥領域多樣化的客戶需求，並實現設計和產能的靈活性。

地緣政治動盪

原因

• 地緣政治緊張局勢加劇，貿易政策被武器化，為醫療包裝製造商帶來了前所未有的波動。主要國家間相對關稅週期性波動，導致關鍵包裝組件的關稅高達336%，徹底顛覆了以往可預測的成本結構。
• 外交衝突往往在極短時間內引發對特種聚合物和藥用級薄膜的突然限制。區域貿易集團的重組也圍繞著政治聯盟而非經濟效率展開，導致原本一體化的供應鏈網路瓦解。

弗羅斯特的展望

未來兩到三年，醫療包裝製造商需要實施先進的貿易資訊系統，以預測關稅變化並避免外交糾紛。企業應將製造地分散到不同的貿易區，並在適當情況下開發區域性生產方案，以規避貿易壁壘。

• 從可能受限的供應商策略性地採購必需材料，對於維持供應鏈和確保獲得關鍵零件至關重要。

分析範圍

這份全面的市場評估報告檢視了醫療保健包裝系統在三大關鍵領域的發展現狀：藥品包裝、醫療設備包裝和輸液袋。報告提供了2021年至2031年（以2024年為基準年）的詳細市場量化數據、成長預測和策略洞察。

本研究專門關注直接用於醫療保健應用的材料和加工後的包裝組件，不包括輔助設備、機械和耗材。市場價值的計算是基於包裝加工商層面，透過價值鏈分析，捕捉原料轉化為專業醫療保健包裝解決方案的關鍵轉折點。

該報告涵蓋美洲、歐洲、中東和非洲、南亞（MEASA）以及亞太地區四大區域，分析了各區域的市場特徵、法規環境和應用趨勢。材料分析部分深入探討了塑膠、玻璃、紙張、金屬和複合材料的消費模式、永續性舉措和創新發展軌跡。

這份評估報告為醫療包裝生態系統中的相關人員提供了可操作的資訊，涵蓋材料供應商、包裝加工商、製藥廠商、醫療設備廠商以及醫療服務提供者。該分析揭示了當前市場動態以及材料科學、法規遵循和患者安全交叉領域這一關鍵方向的新興機會。

平均價格

每噸

成長促進因素

• 醫療保健行業的成長和監管合規要求正在推動對藥品包裝的需求。
• 醫療設備產業的擴張為專業包裝解決方案創造了持續的需求。
• 醫療保健支出不斷成長以及製藥廠數量增加將推動包裝需求。
• 對具有增強功能的高附加價值藥品包裝材料的需求將推動收入成長。

成長抑制因素

• 嚴格的監管要求和冗長的檢驗過程對創新構成了重大障礙。
• 材料成本波動和供應鏈中斷給可預測的生產和開發帶來了挑戰。
• 儘管優質包裝解決方案具有性能優勢，但由於醫療保健成本控制措施的限制，其應用受到限制。
• 平衡永續性目標與基本績效要求的技術挑戰；

目錄

調查範圍

• 分析範圍
• 分割
• 地理覆蓋範圍

成長環境：醫療包裝產業的轉型

• 為什麼成長變得越來越難？
• The Strategic Imperative 8（TM）
• 三大策略挑戰對醫療包裝產業的影響

醫療包裝生態系統

• 價值鏈概覽
• 價值鏈分析
• 競爭環境
• 主要競爭對手：醫藥包裝
• 定義
• PVC的現狀及其對醫用輸液袋產業的影響

醫療包裝中的成長要素

• 成長指標
• 成長促進因素
• 成長促進因素分析
• 成長抑制因素
• 預測考量
• 收入預測
• 收入預測分析
• 按包裝應用分類的收入預測
• 按包裝應用分類的收入預測分析
• 按材料類型分類的收入預測
• 按材料類型分類的收入預測分析
• 按地區分類的收入預測
• 按地區分類的收入預測分析

藥品包裝的成長要素

• 功能概述
• 成長指標
• 收入預測
• 收入預測分析
• 按材料類型分類的收入預測
• 按材料類型分類的收入預測分析
• 按地區分類的收入預測
• 按地區分類的收入預測分析

醫療設備包裝的成長要素

• 功能概述
• 成長指標
• 收入預測
• 收入預測分析
• 按材料類型分類的收入預測
• 按材料類型分類的收入預測分析
• 按地區分類的收入預測
• 按地區分類的收入預測分析

點滴袋成長要素

• 功能概述
• 成長指標
• 收入和預測
• 收入預測分析
• 按材料類型分類的收入預測
• 按材料類型分類的收入預測分析
• 按地區分類的收入預測
• 按地區分類的收入預測分析

醫療包裝市場的成長機遇

• 成長機會 1：敏感治療藥物的溫控包裝
• 成長機會 2：永續醫療保健包裝解決方案
• 成長機會三：貿易不確定性下的策略性回流

附錄與後續步驟

• 成長機會帶來的益處和影響
• 下一步
• 附件清單
• 免責聲明

Medical and Pharmaceutical Packaging is Experiencing Transformational Growth Due to Rising Healthcare Expenditure and Compliance Requirements

This comprehensive analysis of the global medical packaging market offers a detailed examination of regional segmentation, revenue metrics, and material trends, spanning the period from 2021 to 2031. By examining historical data and projecting future trends, the study provides a seven-year forecast from 2025 to 2031, with 2024 serving as the base year.

• By product category: Pharmaceutical Packaging, Medical Device Packaging, and Medical Fluid Bags
• By material: Plastics, Glass, and Others (including metals, paper-based materials, and composites)
• By region: Americas, Europe, Asia-Pacific (APAC), and the Middle East, South Asia, and Africa (MEASA)

The Americas region, with the United States at the forefront, represents a significant market for healthcare packaging, driven by the region's advanced pharmaceutical and medical device manufacturing, extensive healthcare infrastructure, and leadership in adopting specialized packaging innovations. Europe maintains a sophisticated healthcare packaging market, heavily influenced by the region's stringent regulatory environment, which focuses on patient safety and sustainability. MEASA shows accelerated growth in healthcare packaging adoption, while APAC represents the most dynamic growth market for healthcare packaging, with China, Japan, and emerging economies driving substantial expansion in production and consumption.

The study's methodology involves an in-depth analysis of the revenue for each packaging category, material type, and region, providing insights into the factors driving growth and potential challenges. The forecast is based on the anticipated compound annual growth rates (CAGRs), offering a strategic view of the market's evolution.

Revenue Forecast

The revenue estimate for the base year is $104.87 billion, with a CAGR of 7.0% for the study period from 2024 to 2031.

The Impact of the Top 3 Strategic Imperatives on the Medical Packaging Industry

Transformative Megatrends

Why

• The California Toxic-Free Medical Devices Act will ban DEHP-containing IV supplies by 2030, targeting materials that comprise up to 80% of some medical devices. DEHP, a plasticizer that makes PVC flexible, has been linked to multiple cancers, including breast, liver, lung, and testicular cancer.
• Medical products can contain up to 40% DEHP by weight, which can lead into medications and fluids administered to patients. This poses particular risks for cancer patients, as DEHP promotes drug resistance and reduces chemotherapy effectiveness. The EU has established similar regulations through MDR and REACH, requiring DEHP-containing devices to be either authorized or withdrawn by July 2030.

Frost Perspective

• Over the next 3 to 5 years, manufacturers must invest in redefining production lines and validation processes for non-PVC materials, despite significant costs. Forward-thinking companies are developing solutions that eliminate DEHP, plasticizers, and phthalates.
• These new products prioritize, extensive validation, and leadership. Although California's ban takes effect in 2023, early market positioning indicates that compliant companies, such as those that can demonstrate both sustainability and safety, will avoid disruption, saving $5 million annually by complying.

Disruptive Technologies

Why

• The pharmaceutical landscape is rapidly shifting toward biological drugs-complex proteins, antibodies, and living cells derived from living organisms. Unlike small-molecule drugs, biologics are highly sensitive to environmental factors (e.g., temperature, light, moisture, and surface interactions), which can lead to degradation through mechanisms such as oxidation, denaturation, and aggregation when exposed to unfavorable conditions.
• Traditional packaging materials may lack compounds or lack adequate barrier properties. Biologics often require precise cold chain management (sometimes at ultra-low temperatures), protection from mechanical stress, and materials that minimize protein adsorption at surfaces to ensure therapeutic efficacy throughout their shelf life.

Frost Perspective

• Over the next 3 to 5 years, pharmaceutical packaging manufacturers must develop specialized materials and delivery systems optimized for biological products. This includes the need for significant R&D to extricate essential barrier properties against temperature, moisture, and mechanical stress while ensuring product integrity. Manufacturers need to focus on advancing engineered solutions to cleaner production processes.
• Production flexibility will be essential. Cleanroom shares will be the new normal, where manufacturers diversify portfolios to accommodate diverse client needs across biologics and pharmaceuticals, enabling flexibility in design and capacity.

Geopolitical Chaos

Why

• Escalating geopolitical tensions are weaponizing trade policy, creating unprecedented volatility for medical packaging manufacturers. Relationally tariff cycles between major economies have imposed duties of up to 336% on key packaging components, transforming once-predictable cost structures.
• Diplomatic conflicts are triggering abrupt restrictions on specialized polymers and pharmaceutical-grade films, often with minimal notice. Regional trade blocs are realigning around political alliances rather than economic efficiency, fragmenting previously integrated supply networks.

Frost Perspective

In the next 2 to 3 years, medical packaging manufacturers must implement sophisticated trade intelligence systems to anticipate tariff changes and diplomatically navigate disruptions. Companies should diversify manufacturing footprints across different trade zones, developing regional production alternatives that circumvent suited trade barriers.

• Strategic sourcing of essential materials from potentially restricted sources will be crucial for maintaining supply chains and guaranteeing access to critical components.

Scope of Analysis

This comprehensive market assessment examines the evolving landscape of healthcare packaging systems across 3 critical segments: pharmaceutical packaging, medical device packaging, and fluid bags. The analysis provides detailed market quantification, growth forecasts, and strategic insights spanning from 2021 to 2031, with 2024 established as the base year.

The study focuses specifically on materials and converted packaging components used directly in healthcare applications, excluding secondary equipment, machinery, and ancillary supplies. Market values are calculated at the packaging converter level, as indicated in the value chain analysis, capturing the critical transformation point where raw materials are converted into specialized healthcare packaging solutions.

Geographic coverage encompasses 4 distinct regions-the Americas, Europe, the Middle East, Africa, South Asia (MEASA), and Asia-Pacific (APAC)-with each region analyzed for unique market characteristics, regulatory environments, and adoption trends. Material analysis provides granular insights into consumption patterns, sustainability initiatives, and innovation trajectories across plastic, glass, paper, metal, and composite substrates.

This assessment delivers actionable intelligence for stakeholders throughout the healthcare packaging ecosystem, from material suppliers and packaging converters to pharmaceutical manufacturers, medical device producers, and healthcare providers. The analysis illuminates both current market dynamics and emerging opportunities in this essential sector where material science, regulatory compliance, and patient safety intersect.

Average Price Representation

$ Per Ton

Growth Drivers

• Healthcare Industry Growth and Regulatory Compliance Drive Pharmaceutical Packaging Demand.
• Expansion in the Medical Device Industry Creates Sustained Demand for Specialized Packaging Solutions.
• Increased Healthcare Expenditure, Coupled With Rising Drug Manufacturing Facilities, Boosts Demand For Packaging.
• Demand for Value-added Pharmaceutical Packaging Materials With Enhanced Functionalities Propels Revenue Growth.

Growth Restraints

• Stringent Regulatory Requirements and Lengthy Validation Processes Create Significant Barriers to Innovation.
• Material Cost Volatility and Supply Chain Disruptions Challenge Predictable Manufacturing and Development.
• Healthcare Cost Containment Initiatives Limit Adoption of Premium Packaging Solutions Despite Performance Benefits.
• Technical Challenges in Balancing Sustainability Objectives With Essential Performance Requirements.

Table of Contents

Research Scope

• Scope of Analysis
• Segmentation
• Geographic Scope

Growth Environment: Transformation in the Medical Packaging Sector

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Medical Packaging Industry

Ecosystem in the Medical Packaging Sector

• Value Chain Overview
• Value Chain Analysis
• Competitive Environment
• Key Competitors-Pharmaceutical Packaging
• Definitions
• Current State of PVC and Its Impact on the Medical Fluid Bags Industry

Growth Generator in the Medical Packaging Sector

• Growth Metrics
• Growth Drivers
• Growth Driver Analysis
• Growth Restraints
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Packaging Application
• Revenue Forecast Analysis by Packaging Application
• Revenue Forecast by Material Type
• Revenue Forecast Analysis by Material Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region

Growth Generator in Pharmaceutical Packaging

• Characteristics and Overview
• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Material Type
• Revenue Forecast Analysis by Material Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region

Growth Generator in Medical Device Packaging

• Characteristics and Overview
• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Material Type
• Revenue Forecast Analysis by Material Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region

Growth Generator in Fluid Bags

• Characteristics and Overview
• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Material Type
• Revenue Forecast Analysis by Material Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region

Growth Opportunity Universe in Medical Packaging Market

• Growth Opportunity 1: Temperature-Controlled Packaging for Sensitive Therapeutics
• Growth Opportunity 2: Sustainable Healthcare Packaging Solutions
• Growth Opportunity 3: Strategic Reshoring Amid Trade Uncertainty

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer